B5 balm for rosacea with sensitive skin
Part of Skin clinical trials.
This trial tests a B5 balm (CICAPLAST BAUME B5+) to see how well it helps people with rosacea and sensitive skin. It aims to reduce redness and improve skin comfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old
- You have rosacea with redness and visible blood vessels, or your rosacea is stable and not currently being treated
- Your facial redness score is mild to moderate (1 to 3 on the CEA scale)
- Your overall skin condition is mild or better (IGA score of 2 or lower)
- Your facial skin feels dry and you have sensitive skin (tested by a stinging reaction to lactic acid)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a specific soothing moisturizer (La Roche-Posay B5 cream) helps people with mild, stable facial eczema. It is a simple, low-risk trial using a cream you can apply at home.
This study tests a special cream to reduce facial redness caused by rosacea, either alone or combined with laser treatment. It aims to help people with persistent redness and visible blood vessels on their face.
This study tests a new facial cream to reduce redness and bumps caused by rosacea, a common skin condition. The cream may help calm inflammation and improve the appearance of affected areas on the face.
This trial tests a product to reduce facial redness and flushing in people with mild sensitive skin. It uses a short infrared light exposure to induce redness and measure improvement.
This study tests a cream called clascoterone (already approved for acne) to see if it can help treat facial rosacea that causes bumps and pimples. Participants will use the cream daily and attend regular check-ups to see if their skin improves.
This trial tests whether a gel containing a growth factor can help calm sensitive skin with redness. If you have persistent facial redness and stinging, this treatment might reduce irritation and improve skin comfort.
Hear when a new Erythematous Telangiectatic Rosacea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.